Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Urology|August 11, 2021
Antibiotic Duration After Urethroplasty: An Attempt at Improving Antibiotic StewardshipWesley Baas, Alexander Parker, Kushan Radadia, et al.
Journal of the American College of Surgeons|December 26, 2012
Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgerySarah A McLaughlin, Sanjay Bagaria, Tammeza Gibson, et al.
Cancer Causes & Control : CCC|July 14, 2021
Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of FloridaKristianna M Fredenburg, Joan Whitlock, Christopher Morris, et al.
The Canadian Journal of Urology|June 26, 2017
Timing interval from peri-prostatic block to biopsy impacts procedural painRam A Pathak, David D Thiel, Alexander Parker, et al.
JMIR Cancer|June 19, 2025
Predicting Early-Onset Colorectal Cancer in Individuals Below Screening Age Using Machine Learning and Real-World Data: Case Control StudyChengkun Sun, Erin Mobley, Michael Quillen, et al.
BMC Urology|October 30, 2020
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressivenessJeanette E Eckel-Passow, Huihuang Yan, Matthew L Kosel, et al.
Cancer|January 3, 2014
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinomaRichard W Joseph, Payal Kapur, Daniel J Serie, et al.
Nature Aging|December 15, 2023
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogrammingAndrea Cipriano, Mahdi Moqri, Sun Y Maybury-Lewis, et al.
Cancer Research|June 2, 2022
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep LearningPaul H Acosta, Vandana Panwar, Vipul Jarmale, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2Richard W Joseph, Jeanette E Eckel-Passow, Ruchi Sharma, et al.
Pageof 3